Skip to main content
Top

Breast Cancer Research

Issue 3/2003

Content (15 Articles)

Open Access Research article

Adolescent diet and risk of breast cancer

A Lindsay Frazier, Catherine Tomeo Ryan, Helaine Rockett, Walter C Willett, Graham A Colditz

Review

Inflammatory breast cancer: Vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model

Kazuo Shirakawa, Hisataka Kobayashi, Jun Sobajima, Daijo Hashimoto, Atsushi Shimizu, Hiro Wakasugi

Open Access Research article

Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype

MJ Núñez-Villar, F Martínez-Arribas, M Pollán, AR Lucas, J Sánchez, A Tejerina, J Schneider

Open Access Research article

C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer

Petr Beneš, Michal Jurajda, Jan Žaloudík, Lydie Izakovičová-Hollá, Jiří Vácha

Commentary

The future of cytotoxic therapy: selective cytotoxicity based on biology is the key

Johann S de Bono, Anthony W Tolcher, Eric K Rowinsky

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine